Table 2.
Patient outcomes, stratified by virological failure
| Overall (n=786) | HIV viral load <1000 copies per mL (n=534) | HIV viral load ≥1000 copies per mL (n=252) | p value | ||
|---|---|---|---|---|---|
| STAMP trial arm | 0·35 | ||||
| Standard of care | 402 (51%) | 267 (50%) | 135 (54%) | .. | |
| Intervention | 384 (49%) | 267 (50%) | 117 (46%) | .. | |
| Received any antimicrobial treatment | 695 (88%) | 457 (86%) | 238 (94%) | 0·0003 | |
| Received tuberculosis treatment | 109 (14%) | 66 (12%) | 43 (17%) | 0·075 | |
| Length of stay, days | 15·0 (8·0–21·0) | 14·0 (5·0–21·0) | 17·0 (14·0–21·0) | 0·018 | |
| Visited ART clinic after discharge | 475 (67%) | 312 (65%) | 163 (72%) | 0·074 | |
| Mortality at 56 days | |||||
| Overall | 156 (20%) | 94 (18%) | 62 (25%) | 0·022 | |
| During hospital admission | 73 (9%) | 50 (9%) | 23 (9%) | 0·92 | |
| After discharge from hospital | 83 (12%) | 44 (9%) | 39 (17%) | 0·0019 | |
Data are n (%) or median (IQR). p values compare HIV viral load below 1000 copies per mL and at least 1000 copies per mL, calculated using χ2 tests for proportions, t tests for means, and Wilcoxon rank sum for medians. ART=antiretroviral therapy.